兔体内可生物降解纳米球包裹的口服齐多夫定的药代动力学
Pharmacokinetics of oral zidovudine entrapped in biodegradable nanospheres in rabbits.
作者信息
Callender D P, Jayaprakash N, Bell A, Petraitis V, Petraitiene R, Candelario M, Schaufele R, Dunn J M, Sei S, Walsh T J, Balis F M
机构信息
Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland 20892, USA.
出版信息
Antimicrob Agents Chemother. 1999 Apr;43(4):972-4. doi: 10.1128/AAC.43.4.972.
Abstract
The pharmacokinetic profile of oral zidovudine entrapped in a 50:50 polyactide-coglycolide matrix (nanospheres) was compared to those of standard oral and parenteral zidovudine formulations in rabbits. The bioavailability of zidovudine nanospheres at 50 mg/kg of body weight was 76%, and this dose achieved prolonged exposure to zidovudine compared to standard formulations without an increase in the drug's peak concentration.
摘要
将包裹于50:50聚丙交酯-乙交酯基质（纳米球）中的口服齐多夫定的药代动力学特征，与兔体内标准口服及肠胃外齐多夫定制剂的药代动力学特征进行了比较。体重50 mg/kg时，齐多夫定纳米球的生物利用度为76%，与标准制剂相比，该剂量实现了对齐多夫定的延长暴露，且未增加药物的峰值浓度。
相似文献
1
Pharmacokinetics of oral zidovudine entrapped in biodegradable nanospheres in rabbits.兔体内可生物降解纳米球包裹的口服齐多夫定的药代动力学
Antimicrob Agents Chemother. 1999 Apr;43(4):972-4. doi: 10.1128/AAC.43.4.972.
2
Pharmacokinetics of zidovudine dosed twice daily according to World Health Organization weight bands in Ugandan HIV-infected children.根据世界卫生组织体重分组，乌干达感染艾滋病毒儿童每日两次服用齐多夫定的药代动力学。
Pediatr Infect Dis J. 2014 May;33(5):495-8. doi: 10.1097/INF.0000000000000143.
3
Time-dependent pharmacokinetic interaction between zidovudine and rifampicin following oral administration at 10.00 and 22.00 hours.齐多夫定与利福平在上午10点和晚上10点口服给药后的时间依赖性药代动力学相互作用。
Drug Metabol Drug Interact. 2001;18(2):123-34. doi: 10.1515/dmdi.2001.18.2.123.
4
Pharmacokinetics of zidovudine following intravenous bolus administration of a novel niosome preparation devoid of cholesterol.静脉推注不含胆固醇的新型脂质体制剂后齐多夫定的药代动力学。
Arzneimittelforschung. 2001 Nov;51(11):924-30. doi: 10.1055/s-0031-1300139.
5
Evaluation of the bioequivalence of zidovudine 100 mg capsules in healthy Thai male volunteers.对100毫克齐多夫定胶囊在健康泰国男性志愿者中的生物等效性评估。
J Med Assoc Thai. 2006 Sep;89 Suppl 3:S79-85.
6
Tissue distribution, pharmacokinetics and stability studies of zidovudine delivered by niosomes and proniosomes.齐多夫定制剂和前体脂质体给药的组织分布、药代动力学和稳定性研究。
J Biomed Nanotechnol. 2010 Feb;6(1):43-51. doi: 10.1166/jbn.2010.1101.
7
Pharmacokinetics of saquinavir, zidovudine, and zalcitabine in combination therapy.沙奎那韦、齐多夫定和扎西他滨联合治疗的药代动力学
Antimicrob Agents Chemother. 1997 Nov;41(11):2428-32. doi: 10.1128/AAC.41.11.2428.
8
Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy Brazilian volunteers: an open-label, randomized, single-dose, two-way crossover study.两种齐多夫定制剂在巴西健康志愿者中的生物等效性和药代动力学：一项开放标签、随机、单剂量、双向交叉研究。
Clin Ther. 2008 May;30(5):902-8. doi: 10.1016/j.clinthera.2008.05.003.
9
Plasma levels of zidovudine twice daily compared with three times daily in six HIV-1-infected children.六名感染HIV-1的儿童中，齐多夫定每日两次与每日三次的血浆水平比较。
J Antimicrob Chemother. 2004 Dec;54(6):1152-4. doi: 10.1093/jac/dkh490. Epub 2004 Nov 10.
10
Pharmacokinetics of oral zidovudine administered during labour: a preliminary study.
HIV Med. 2007 Oct;8(7):451-6. doi: 10.1111/j.1468-1293.2007.00495.x.
引用本文的文献
1
Improved Safety, Bioavailability and Pharmacokinetics of Zidovudine through Lactoferrin Nanoparticles during Oral Administration in Rats.乳铁蛋白纳米颗粒在大鼠口服给药期间提高齐多夫定的安全性、生物利用度和药代动力学
PLoS One. 2015 Oct 13;10(10):e0140399. doi: 10.1371/journal.pone.0140399. eCollection 2015.
2
Composite alginate hydrogel microparticulate delivery system of zidovudine hydrochloride based on counter ion induced aggregation.基于反离子诱导聚集的盐酸齐多夫定复合藻酸盐水凝胶微粒给药系统
Int J Appl Basic Med Res. 2014 Sep;4(Suppl 1):S31-6. doi: 10.4103/2229-516X.140728.
3
Alginate nanoparticles as a promising adjuvant and vaccine delivery system.海藻酸盐纳米颗粒作为一种有前景的佐剂和疫苗递送系统。
Indian J Pharm Sci. 2013 Jul;75(4):442-9. doi: 10.4103/0250-474X.119829.
4
Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics.麦醇溶蛋白纳米颗粒作为亲脂性药物口服给药的载体。生物黏附与药代动力学之间的关系。
Pharm Res. 2001 Nov;18(11):1521-7. doi: 10.1023/a:1013018111829.
本文引用的文献
1
In vivo evaluation of zidovudine (AZT)-loaded ethylcellulose microspheres after oral administration in beagle dogs.齐多夫定（AZT）负载乙基纤维素微球经口给药后在比格犬体内的评价
J Pharm Sci. 1997 May;86(5):554-9. doi: 10.1021/js960461b.
2
Clinical pharmacokinetics of zidovudine. An update.齐多夫定的临床药代动力学。最新进展。
Clin Pharmacokinet. 1996 Apr;30(4):251-62. doi: 10.2165/00003088-199630040-00001.
3
The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites.齐多夫定剂量对细胞内磷酸化代谢物形成的影响。
AIDS. 1996 Oct;10(12):1361-7. doi: 10.1097/00002030-199610000-00008.
4
Preparation of biodegradable microcapsules containing zidovudine (AZT) using solvent evaporation technique.采用溶剂蒸发技术制备含齐多夫定（AZT）的可生物降解微胶囊。
J Microencapsul. 1996 May-Jun;13(3):257-67. doi: 10.3109/02652049609026014.
5
Preparation and evaluation of sustained release AZT-loaded microspheres: optimization of the release characteristics using response surface methodology.
J Pharm Sci. 1996 Feb;85(2):144-9. doi: 10.1021/js950353+.
6
Noncompartmental determination of the steady-state volume of distribution for any mode of administration.非房室模型法测定任何给药方式下的稳态分布容积。
J Pharm Sci. 1982 Mar;71(3):372-3. doi: 10.1002/jps.2600710332.
7
8
Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection.齐多夫定在感染人类免疫缺陷病毒的儿童中静脉内和口服给药的药代动力学。
J Pediatr. 1989 May;114(5):880-4. doi: 10.1016/s0022-3476(89)80158-1.
9
The pharmacokinetics of zidovudine administered by continuous infusion in children.齐多夫定在儿童中持续静脉输注给药的药代动力学。
Ann Intern Med. 1989 Feb 15;110(4):279-85. doi: 10.7326/0003-4819-110-4-279.
Zotero 插件